Clinical Study
The Effect of Pramipexole Therapy on Balance Disorder and Fall Risk in Parkinson’s Disease at Early Stage: Clinical and Posturographic Assessment
Table 2
Clinical results data.
| | Patients group | Control group | Patient group | Control group | Patient group | | | (before drug usage) | (baseline) | (1.5 mg PM) | (After 1.5 months) | (3 mg PM) | | | Mean | Mean | Mean | Mean | Mean | |
| H&Y (mean) | 2 | | 1.5 | | 1 | <0.001 | UPDRS (sum-mean) | 33 | | 28 | | 22 | <0.001 | UPDRS (mental-mean) | 3 | | 2.5 | | 2 | <0.001 | UPDRS (DLA-mean) | 13.5 | | 12.5 | | 9 | <0.001 | UPDRS (M-mean) | 13.5 | | 12.5 | | 8.5 | <0.001 | BBS (PvC-mean) | 51 | 54 | | | | <0.001 | BBS (PvC-mean) | | | | 55 | 53 | <0.001 | BBS (P-mean) | 51 | | 52 | | 53 | <0.001 |
|
|
DLA: daily living activities, P: patient, C: control, and M: motor.
|